Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab.

Andrea Harrer; Roland Lang; Peter Kölblinger

doi:10.1111/bjd.19137

Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab.

Andrea Harrer^* (First author), Roland Lang (Co-author), Peter Kölblinger (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Letter to the editor › peer-review

Original language	English
Pages (from-to)	404
Journal	BRITISH JOURNAL OF DERMATOLOGY
Volume	183
Issue number	2
DOIs	https://doi.org/10.1111/bjd.19137
Publication status	Published - 2020

Access to Document

10.1111/bjd.19137

Cite this

@article{3a344959258745ddba32697afb8b3f4a,

title = "Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab.",

author = "Andrea Harrer and Roland Lang and Peter K{\"o}lblinger",

note = "Harrer: Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria; Department of Neurology, Paracelsus Medical University, Salzburg, Austria; all: Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria; ",

year = "2020",

doi = "10.1111/bjd.19137",

language = "English",

volume = "183",

pages = "404",

journal = "BRITISH JOURNAL OF DERMATOLOGY",

issn = "0007-0963",

publisher = "Blackwell Verlag",

number = "2",

}

Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab. / Harrer, Andrea (First author); Lang, Roland (Co-author); Kölblinger, Peter (Last author).
In: BRITISH JOURNAL OF DERMATOLOGY, Vol. 183, No. 2, 2020, p. 404.

Research output: Contribution to journal › Letter to the editor › peer-review

TY - JOUR

T1 - Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab.

AU - Harrer, Andrea

AU - Lang, Roland

AU - Kölblinger, Peter

N1 - Harrer: Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria; Department of Neurology, Paracelsus Medical University, Salzburg, Austria; all: Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria;

PY - 2020

Y1 - 2020

U2 - 10.1111/bjd.19137

DO - 10.1111/bjd.19137

M3 - Letter to the editor

C2 - 32319671

SN - 0007-0963

VL - 183

SP - 404

JO - BRITISH JOURNAL OF DERMATOLOGY

JF - BRITISH JOURNAL OF DERMATOLOGY

IS - 2

ER -